1091 related articles for article (PubMed ID: 22986158)
1. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
2. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of quercetin on rat urinary bladder after spinal cord injury.
Cevik O; Erşahin M; Sener TE; Tinay I; Tarcan T; Cetinel S; Sener A; Toklu HZ; Sener G
J Surg Res; 2013 Aug; 183(2):695-703. PubMed ID: 23490140
[TBL] [Abstract][Full Text] [Related]
4. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast.
Sener G; Sehirli O; Cetinel S; Ercan F; Yüksel M; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):453-62. PubMed ID: 16162403
[TBL] [Abstract][Full Text] [Related]
6. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
7. Melatonin treatment protects against spinal cord injury induced functional and biochemical changes in rat urinary bladder.
Erşahin M; Özdemir Z; Özsavcı D; Akakın D; Yeğen BÇ; Reiter RJ; Sener G
J Pineal Res; 2012 Apr; 52(3):340-8. PubMed ID: 22220508
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
9. Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats.
Ozkan E; Yardimci S; Dulundu E; Topaloğlu U; Sehirli O; Ercan F; Velioğlu-Oğünç A; Sener G
J Surg Res; 2010 Mar; 159(1):588-94. PubMed ID: 19515388
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin alleviates spinal cord injury in rats via its anti-inflammatory effects.
Erşahın M; Toklu HZ; Erzık C; Akakin D; Tetık S; Sener G; Yeğen BC
Turk Neurosurg; 2011; 21(4):599-605. PubMed ID: 22194122
[TBL] [Abstract][Full Text] [Related]
11. Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast.
Kabasakal L; Sener G; Cetinel S; Contuk G; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):431-40. PubMed ID: 15890506
[TBL] [Abstract][Full Text] [Related]
12. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
13. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats.
Dulundu E; Ozel Y; Topaloglu U; Sehirli O; Ercan F; Gedik N; Sener G
Pharmacology; 2007; 79(3):163-70. PubMed ID: 17259747
[TBL] [Abstract][Full Text] [Related]
14. Meloxicam exerts neuroprotection on spinal cord trauma in rats.
Hakan T; Toklu HZ; Biber N; Celik H; Erzik C; Oğünç AV; Çetinel S; Sener G
Int J Neurosci; 2011 Mar; 121(3):142-8. PubMed ID: 21138398
[TBL] [Abstract][Full Text] [Related]
15. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa.
Sener G; Kapucu C; Cetinel S; Cikler E; Ayanoğlu-Dülger G
Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):1-11. PubMed ID: 15589394
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of alpha-lipoic acid in experimental spinal cord injury in rats.
Toklu HZ; Hakan T; Celik H; Biber N; Erzik C; Ogunc AV; Akakin D; Cikler E; Cetinel S; Ersahin M; Sener G
J Spinal Cord Med; 2010; 33(4):401-9. PubMed ID: 21061900
[TBL] [Abstract][Full Text] [Related]
17. Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.
Sener G; Sehirli O; Toklu H; Ercan F; Alican I
J Pharm Pharmacol; 2007 Jun; 59(6):837-42. PubMed ID: 17637175
[TBL] [Abstract][Full Text] [Related]
18. Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats.
Cavus G; Altas M; Aras M; Ozgür T; Serarslan Y; Yilmaz N; Sefil F; Ulutas KT
Eur Rev Med Pharmacol Sci; 2014; 18(12):1770-7. PubMed ID: 24992621
[TBL] [Abstract][Full Text] [Related]
19. Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury.
Gideroglu K; Yilmaz F; Aksoy F; Bugdayci G; Saglam I; Yimaz F
J Surg Res; 2009 Dec; 157(2):181-6. PubMed ID: 19589545
[TBL] [Abstract][Full Text] [Related]
20. The effects of montelukast against amikacin-induced acute renal damage.
Kose E; Beytur A; Dogan Z; Ekincioglu Z; Vardi N; Cinar K; Turkoz Y; Soysal H; Ekinci N
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):503-11. PubMed ID: 22696878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
